Y-mAbs Therapeutics, Inc. (YMAB) Revenue Breakdown by Product (Quarterly) - Discounting Cash Flows
  • Enter your search keyword...
YMAB
Y-mAbs Therapeutics, Inc.
YMAB (NASDAQ)
  • Financials

  • Y-mAbs Therapeutics, Inc. Revenue Breakdown

Annual Quarterly

* (except for per share items) of USD
Period Ending: 2025 (Q2)
06-30 		2025 (Q1)
03-31 		2024 (Q4)
12-31 		2024 (Q3)
09-30 		2024 (Q2)
06-30 		2024 (Q1)
03-31 		2023 (Q4)
12-31 		2023 (Q3)
09-30 		2023 (Q2)
06-30 		2022 (Q4)
12-31 		2022 (Q3)
09-30 		2022 (Q2)
06-30 		2022 (Q1)
03-31 		2021 (Q4)
12-31 		2021 (Q3)
09-30 		2021 (Q2)
06-30 		2021 (Q1)
03-31
Total
1234
License
1234
License (%)
1234
Product
1234
Product (%)
1234
Product, DANYELZA
1234
Product, DANYELZA (%)
1234

AI Insights

What are AI Insights?

AI Insights help you understand your data more easily. With just a click, the assistant looks at the current page, generates a report with key metrics, and highlights any interesting trends, patterns, or outliers. You can also ask the assistant follow-up questions.

Create a Free Account
AI Insights Example
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program

Ready to Leave?

Select "Logout" below if you are ready to end your current session.